Mucosal Leishmaniasis
Also known as: Leishmaniasis, Mucocutaneous / Mucocutaneous Leishmaniasis / Mucocutaneous infection caused by Leishmania (disorder) / Espundia / Infection by Leishmania braziliensis (disorder) / American mucocutaneous leishmaniasis (disorder) / Cutaneous, american leishmaniasis / Cutaneous leishmaniasis, American / Infection by Leishmania mexicana (disorder) / L.braziliensis / Leishmania braziliensis infection
Drug | Drug Name | Drug Description |
---|---|---|
DB00681 | Amphotericin B | An antifungal used to treat fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis. |
DB09031 | Miltefosine | An antileishmanial agent used to treat leishmaniasis, a group of disease caused by parasites of the Leishmania type. |
DB05630 | Sodium stibogluconate | For the treatment of various types of a protozoal infection called leishmaniasis, which may result from sandfly bites in tropical and temperate parts of the world. Also investigated for use/treatment... |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00681 | Amphotericin B | Ergosterol | target |
DB09031 | Miltefosine | Phospholipase D1 | enzyme |
DB09031 | Miltefosine | P-glycoprotein 1 | target |
DB05630 | Sodium stibogluconate | DNA topoisomerase 1 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB13732 | Meglumine antimoniate | 2 | Completed | 1 |
DB09031 | Miltefosine | 2 | Completed | 2 |
DB00681 | Amphotericin B | 2 / 3 | Recruiting | 1 |
DB13732 | Meglumine antimoniate | 2 / 3 | Unknown Status | 1 |
DB09031 | Miltefosine | 2 / 3 | Recruiting | 1 |
DB00806 | Pentoxifylline | 2 / 3 | Recruiting | 1 |
DB00681 | Amphotericin B | 3 | Recruiting | 1 |
DB09031 | Miltefosine | 3 | Recruiting | 1 |
DB13047 | Pentavalent Antimony | 3 | Recruiting | 1 |
DB09031 | Miltefosine | Not Available | Completed | 2 |
DB05630 | Sodium stibogluconate | Not Available | No Longer Available | 1 |